JonathanIanSilverbergMD
Dermatology • Washington, DCAssociate Professor of Dermatology, George Washington University School of Medicine and Health Sciences
Dr. Silverberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2150
Ste 2B-430
Washington, DC 20037
Summary
- Dr. Jonathan Silverberg is a dermatologist in Washington, DC and is affiliated with George Washington University School of Medicine and Health Sciences. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 8 years. He is experienced in general dermatology, atopic dermatitis, contact dermatitis, allergic contact dermatitis, and eczema.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Dermatology, 2010 - 2013
SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 2009 - 2010
State University of New York Downstate Medical Center College of MedicineClass of 2009
Certifications & Licensure
OR State Medical License 2012 - Present
DC State Medical License 2019 - 2024
MD State Medical License 2019 - 2021
IL State Medical License 2013 - 2020
NY State Medical License 2012 - 2014- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 3050 citationsHealth Effects of Overweight and Obesity in 195 Countries over 25 Years.Ashkan Afshin, Mohammad H. Forouzanfar, Marissa B Reitsma, Patrick J Sur, Kara Estep
The New England Journal of Medicine. 2017-07-06 - 445 citationsTwo Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.Eric L Simpson, Thomas Bieber, Emma Guttman-Yassky, Lisa A Beck, Andrew Blauvelt
The New England Journal of Medicine. 2016-12-15 - 3945 citationsGlobal, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Glo...Haidong Wang, Mohsen Naghavi, Christine Allen, Ryan M Barber, Zulfiqar A Bhutta
Lancet. 2016-10-08
Journal Articles
- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Hernan Valdez, JAMA Dermatology
- Dupilumab Provides Important Clinical Benefits to Patients with Atopic Dermatitis Who Do Not Achieve Clear or Almost Clear Skin According to the Investigator's Global ...J I Silverberg, The British Journal of Dermatology
- Inpatient Burden of Juvenile Dermatomyositis Among Children in the United StatesMichael C Kwa, Jonathan I Silverberg, BioMed Central
- Join now to see all
Authored Content
- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJune 2020
Press Mentions
Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin DiseasesOctober 29th, 2024- Clues to Improving the Quality of Life of Patients with Chronic UrticariaOctober 3rd, 2024
- Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Atopic Dermatitis, a Chronic Skin ConditionSeptember 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
